Grail continues facing significant challenges as its stock plummeted over 45% after its landmark NHS-Galleri trial failed to ...
The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U.S. Sales Force Expansion Based on ...
Sold More Than 185,000 Galleri® Tests in 2025, Growing U.S. Galleri Revenue 26% Year-Over-Year to $136.8 Million Completed Galleri PMA Submission to FDA Shared Topline ...
Preventive healthcare in India is changing gears. Little by little, one measurement at a time, health systems are moving from treating disease to spotting it early ...
Wilmington, Delaware - February 02, 2026 - PRESSADVANTAGE - PSCI shared perspective on how artificial intelligence is ...
Artificial Intelligence] is everywhere,” professor and vice chair of research in the University of Wisconsin Department of Radiology, Dr. Christoph Lee, said. Currently, UW is participating in a multi ...
AUSTIN, TX, UNITED STATES, February 18, 2026 /EINPresswire.com/ -- The Artificial Intelligence Board of America ...
DUBAI, UNITED ARAB EMIRATES, February 4, 2026 /EINPresswire.com/ -- Actxa, a Singapore-based preventive health brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results